Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMRN | AMGN | BMY | VRTX | GILD |
| Company | Biomarin Pharmaceuticals | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 62.40 | 288.18 | 58.16 | 454.24 | 89.07 |
| High | 63.76 | 291.11 | 58.48 | 455.43 | 89.94 |
| Low | 61.41 | 284.14 | 57.47 | 445.00 | 88.07 |
| Last | 63.46 | 289.88 | 58.23 | 450.37 | 89.75 |
| Change | +0.90 | +2.01 | +0.35 | -0.86 | +1.12 |
| % Change | +1.44% | +0.70% | +0.60% | -0.19% | +1.26% |
| Volume | 966,372 | 2,185,866 | 5,635,666 | 1,108,776 | 2,619,953 |
| 20-Day Average Volume | 1,569,587 | 2,840,502 | 12,273,399 | 1,319,064 | 7,439,888 |
| Previous Close | 62.56 | 287.87 | 57.88 | 451.23 | 88.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 65.97 | 307.43 | 55.92 | 479.21 | 90.89 |
| 20-Day Raw Stochastic | 24.82% | 27.67% | 69.42% | 6.42% | 28.47% |
| 20-Day Relative Strength | 33.96% | 36.69% | 60.74% | 40.77% | 53.52% |
| Weighted Alpha | -33.47 | +2.04 | +26.09 | +17.90 | +26.01 |
| Today's Opinion | 100% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 100% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 88% Sell | 8% Buy | 88% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.06% since 11/14/24 | -1.96% since 11/14/24 | -0.44% since 11/14/24 | -7.03% since 11/14/24 | -2.58% since 11/14/24 |
| Low | 61.15 on 11/19/24 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.13 on 11/21/24 | 86.08 on 11/19/24 |
| High | 66.05 on 11/15/24 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 91.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | -9.52% since 10/21/24 | -8.40% since 10/21/24 | +11.75% since 10/21/24 | -5.89% since 10/21/24 | +3.99% since 10/21/24 |
| Low | 61.15 on 11/19/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.13 on 11/21/24 | 85.60 on 10/22/24 |
| High | 70.98 on 10/25/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -31.31% since 08/21/24 | -11.85% since 08/21/24 | +20.24% since 08/21/24 | -7.44% since 08/21/24 | +19.43% since 08/21/24 |
| Low | 61.15 on 11/19/24 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.13 on 11/21/24 | 75.35 on 08/22/24 |
| High | 93.04 on 08/29/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -17.78% since 05/21/24 | -7.85% since 05/21/24 | +37.79% since 05/21/24 | +1.79% since 05/21/24 | +33.35% since 05/21/24 |
| Low | 61.15 on 11/19/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 94.85 on 08/20/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,922,872 | 154,739,632 | 117,390,888 | 116,204,808 | 110,456,552 |
| Shares Outstanding, K | 190,583 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 2,419,230,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | 167,650,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 745,740,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | 106,080,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.31 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.91 on 10/29/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 10/29/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 27.42 | 14.57 | 49.77 | 0.00 | 19.81 |